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Exposure to maternal obesity or hyperglycaemia increases the risk of obesity and poor glucose 
tolerance in the offspring. We hypothesized that maternal overnutrition in late pregnancy  would 
result in lower  methylation in the promoter region of the cytosolic form of phosphoenolpyruvate 
carboxykinase (PEPCK-C; PCK1) and higher expression of  hepatic gluconeogenic factors in the 
fetal and postnatal lamb. 
Methods: 
Ewes were fed  100% (n=18) or ~155% (n=17) of energy requirements from 115 days gestation 
and livers collected at ~140 days gestation or 30 days postnatal age. 
Results: 
Maternal overnutrition resulted in a decrease in hepatic expression of the mitochondrial form of 
PEPCK (PEPCK-M; PCK2) but not PEPCK-C or glucose-6-phosphatase (G6PHOS) before and 
after birth. Hepatic expression of peroxisome proliferator-activated receptor gamma co-activator 
1 (PGC-1), peroxisome proliferator-activated receptor α (PPARα), PEPCK-C, G6PHOS and 11β 
hydroxysteroid  dehydrogenase  type  1  (11βHSD1),  but  not  PEPCK-M,  was  higher  in  the 
postnatal compared to the fetal lamb. The level of PCK1 methylation was paradoxically ~2 fold 
higher in the postnatal compared to the fetal liver. 
Conclusions: 
Maternal overnutrition programs a decrease in hepatic PEPCK-M in offspring and as ~50% of 






In  pregnancies  complicated  by  maternal  diabetes  mellitus,  gestational  diabetes  or  mildly 
impaired glucose tolerance, offspring are at risk of developing obesity and glucose intolerance 
(1-3). It has therefore been proposed that exposure to maternal and hence fetal hyperglycaemia 
may result in permanent metabolic changes within insulin sensitive tissues and the programming 
of an increased body fat mass, glucose intolerance and insulin resistance in later life (4,5). 
Exposure to maternal overnutrition during the last 30-40 days of gestation in the pregnant ewe 
results in fetal hyperglycaemia and an increase in fasting plasma glucose concentrations and in 
body fat deposition in the postnatal lamb (6). It is not clear, however, whether the metabolic 
consequences of exposure to maternal overnutrition are solely due to the increase in body fat 
mass in the offspring or whether they represent the outcome of programmed changes in insulin 
sensitive tissues, such as the liver, in addition to those changes which occur in adipose tissue to 
increase fat deposition. 
Hepatic peroxisome proliferator-activated receptor gamma co-activator 1 (PGC-1), induces fatty 
acid oxidation in the liver by co-activating the transcription factor peroxisome proliferator- 
activated  receptor  α  (PPARα)  and  also  induces  expression  of  the  hepatic  gluconeogenic 
enzymes, phosphoenolpyruvate carboxykinase (PEPCK-C; PCK1) and glucose-6-phosphatase 
(G6PHOS). PEPCK is the rate-limiting enzyme which regulates hepatic gluconeogenesis and it 
has been shown that exposure to chronic hypoxemia, hypoglycemia and glucocorticoids increase 
hepatic PEPCK and gluconeogenesis in the fetal sheep (7-10). There is also an increase in 
hepatic gluconeogenic enzyme activity with increasing gestational age which is dependent on the 
normal pre-partum rise in fetal cortisol (7). 
The enzyme11β hydroxysteroid dehydrogenase type 1 (11βHSD1) catalyses the inter-conversion 
of active cortisol and inert 11-dehydrocortisol (11). 11βHSD1 is highly expressed in liver, where 
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the reaction direction is 11β-reduction, potentially resulting in an increase in intra-hepatic 
cortisol. Suppression of hepatic 11βHSD1 expression and enzyme activity results in a reduced 
expression of hepatic PEPCK, suggesting that 11βHSD1 plays an important role in maintaining 
expression of key glucocorticoid-regulated hepatic transcripts (12). Whilst exposure to excess 
prenatal glucocorticoids or poor maternal nutrition can permanently program abnormal glucose 
metabolism in the offspring (13), it is not known whether maternal overnutrition has an effect on 
expression of either the glucocorticoid receptor (GR) or 11βHSD1 in the liver before or after 
birth. 
PEPCK is present in two isoforms in the liver, cytosolic PEPCK (PEPCK-C: PCK1) and 
mitochondrial PEPCK (PEPCK-M: PCK2). It is well established that mRNA and protein 
abundance of the cytosolic or inducible form of PEPCK are highly correlated and the role of 
PEPCK-C in gluconeogenesis as well as its transcriptional regulation in development has been 
extensively investigated (14-17). While 50% of total PEPCK activity in the livers of most 
mammals,  is comprised of PEPCK-M, there is relatively little  known about the role of PEPCK-
M during development (14,17).  
Epigenetic modification of key genes plays a role in metabolic programming through a range of 
mechanisms including methylation of CpG sites in the promoter regions of key genes including 
PCK1 (17,18). While maternal undernutrition results in a decrease in the level of methylation in 
the PCK1 promoter and a concomitant increase in PEPCK-C expression in the fetal baboon liver 
(19), there have been no studies on the impact of maternal overnutrition on the methylation of 
the PCK1 promoter in the liver of either the fetus or offspring. In this study, we have therefore 
investigated the effects of maternal overnutrition during late gestation in the sheep on the 
expression of PGC-1, PPARα, PEPCK-C, PEPCK-M, G6PHOS, glucose transporter-1 (GLUT-
1), GR and 11βHSD1 and on the level of methylation of the PCK1 promoter at 3 CpG sites (-49, 




Maternal overnutrition and relative fetal and lamb liver weight 
There was no difference in fetal arterial PO2 (Control, 22.8 ±.6 mm Hg; WF, 21.8 ± 0.4 mm Hg), 
PCO2 (Control, 49.9 ± 0.7 mm Hg; WF, 51.0 ± 0.9 mm Hg), or pH (Control, 7.39 ± 0.002; WF, 
7.39 ± 0.005) between the WF and Control groups throughout late gestation. Maternal plasma 
glucose concentrations were 3.5± 0.2 mmoll-1 and 3.0 ± 0.2 mmoll-1in the WF and Control 
groups respectively in late gestation. Mean plasma glucose concentrations were higher in the WF 
group in both fetuses and lambs (Table 2). Plasma insulin concentrations were higher in fetuses, 
but not in lambs, in the WF group compared to Controls (Table 2). There was no impact of 
exposure to maternal overnutrition on the plasma cortisol concentrations in either fetuses or 
lambs (Table 2). 
There was no difference between the relative liver weight in fetuses in the WF and Control 
groups at 139-141 days gestation (Control, 28.0 ± 2.3 g/kg; WF, 26.0 ± 1.4 g/kg). In the 
postnatal lambs, however, relative liver weight was significantly greater in the lambs of the WF 
compared to the Control group at 30 days postnatal age (WF, 21.7 ± 0.59 g/kg; Control, 19.4 ± 
0.57 g/kg, P<0.05). 
Maternal overnutrition and hepatic gene expression in the fetal and postnatal lamb 
Hepatic expression of PEPCK-M mRNA was lower in the fetal and postnatal lambs in the WF 
group compared to Controls (Figure 1a). Whilst there was also a trend (P<0.06) for hepatic 
PEPCK-C mRNA expression to be lower in the fetuses of the WF group, there was no effect of 
exposure to maternal overnutrition on hepatic PEPCK-C mRNA expression in the postnatal lamb 
(Figure 1b). There was no effect of exposure to maternal overnutrition, on the hepatic expression 
of PGC-1, PPARα, G6PHOS, GLUT-1 and 11βHSD1 mRNA either before or after birth 
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(Figures 2-5). There was also no effect of maternal overnutrition on the hepatic expression of 
GR either before or after birth (Fetal: Control, 0.50 ± 0.20, WF, 0.62 ± 0.11; Postnatal, Control, 
0.44 ± 0.02, WF, 0.43 ± 0.02), or G6PHOS mRNA in the postnatal lamb (Control, 0.032 ± 
0.005, WF, 0.041± 0.005).  
The levels of expression of PEPCK-C, PGC-1, PPARα and 11βHSD1 mRNA levels were 
significantly higher, whereas GLUT-1 mRNA expression was lower, in the liver of the postnatal 
lamb compared to the fetus, independent of the level of maternal nutrition (Figures 1b, 2-5). 
G6PHOS mRNA levels were not detectable in the fetus but increased after birth in both the 
Control and WF groups. There was no difference in GR mRNA expression between the fetuses 
and postnatal lambs (Fetal; 0.56 ±0.21, Postnatal 0.43 ±0.02).  
Furthermore, there was no relationship between the hepatic expression of these genes and the 
plasma concentrations of glucose, insulin or cortisol concentrations in either the fetus or 
postnatal lamb.   
Relationships between hepatic PGC-1, PPARα and gluconeogenic gene expression in the 
sheep fetus and postnatal lamb 
There was a direct relationship between the hepatic expression of PGC-1 and PEPCK-M mRNA 
(y= 6.39x - 0.04; r2= 0.34, P =0.016, n=14) in the fetal but not the postnatal cohort.  In contrast, 
there was no relationship between hepatic PGC-1 and PEPCK-C mRNA expression before birth.  
In the postnatal cohort, however, both PEPCK-C mRNA (y= 18.32x + 3.15; r2= 0.60, 
P<0.00001, n=19) and G6PHOS mRNA expression (y= 0.34x + 0.01; r2=0.38, P= 0.004, n=19) 
were directly related to hepatic PGC-1 mRNA expression. 
PCK1 promoter methylation 
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The level of methylation at each of the 3 CpG sites in the PCK1 promoter was relatively low 
(~3-10%) in the late gestation sheep fetus (Table 3). There was no impact of maternal 
overnutrition on the level of methylation at any CpG site in PCK1 in the liver of either the late 
gestation sheep fetus or postnatal lamb (Figure 5).  The level of methylation at each site 





Maternal overnutrition and liver growth in the offspring 
Whilst previous studies have shown that exposure to maternal global undernutrition or low 
protein diets result in altered liver growth and morphology (27-32), this study has found that 
there is an impact of maternal overnutrition in late pregnancy on liver size in early postnatal life. 
Interestingly there is also evidence that gestational diabetes is associated with an increase in liver 
size in the human fetus in mid gestation (33). Previous studies in the rodent have shown that 
high  fat  feeding  during  pregnancy  results  in  an  increase  in  liver  weight (34) and  in  liver 
triglyceride content in the offspring (34,35). Similarly, experimental induction of gestational 
diabetes in the rodent results in postnatal obesity and in changes in liver fatty acid composition 
and very-low-density lipoprotein (VLDL) lipid concentrations (36). Exposure to maternal 
overnutrition during late pregnancy results in an increase in subcutaneous body fat mass in the 
postnatal lamb but this occurs in the absence of an increase in circulating free fatty acid 
concentrations (37). Whilst an increase in lipid deposition in the liver appears unlikely to explain 
the increase in liver size in WF lambs, an increase in liver triglyceride content requires further 
investigation. An alternative explanation may be that an increase in fetal substrate supply 
programs an up-regulation of the expression of hepatic growth factors to induce hypertrophy or 
hyperplasia of hepatocytes after the transition to the postnatal nutritional environment.  
Maternal overnutrition and hepatic gluconeogenic gene expression 
An increase in maternal and fetal nutrition resulted in a significant suppression in PEPCK-M 
mRNA expression and a trend towards a decrease in PEPCK-C mRNA expression in the fetal, 
but not postnatal liver. These data highlight that the expression of the mitochondrial and 
cytosolic forms of PEPCK in the fetal liver are each sensitive to an increase in the prevailing 
glucose and/or insulin concentrations in late gestation. Interestingly the decrease in hepatic 
10 
 
PEPCK-M, but not PEPCK-C, mRNA expression persisted in postnatal lambs which had been 
exposed to maternal overnutrition in late gestation. One possibility is that the suppression of 
PEPCK-M mRNA expression in the postnatal liver is related to the presence of higher 
circulating glucose concentrations in the lambs of the WF group. There was no difference, 
however, in the level of PEPCK-M expression between the fetal and postnatal liver despite the 
markedly higher plasma glucose concentrations in postnatal compared to fetal life.  Exposure  to  
maternal  overnutrition  in  late gestation may therefore program a persistent suppression of 
PEPCK-M expression in the offspring. PEPCK-M plays a role within the hepatic cell in 
balancing the cytosolic redox state during gluconeogenesis from lactate by synthesizing P-
enolpyruvate directly in the mitochondria. This ensures that only one molecule of NADH is 
produced during the production of glucose from lactate (17). Thus a persistent suppression of 
PEPCK-M may have deleterious consequences for the hepatocyte in later life. Whilst PEPCK-C 
expression  may  be  altered  by  a  number  of  epigenetic  modifications  including  DNA  and 
chromatin methylation (17), nothing is currently known about factors which may result in a 
persistent down regulation of hepatic PEPCK-M expression. 
Transition to postnatal nutrition and gluconeogenic gene expression 
Consistent with previous studies in other tissues, GLUT-1 mRNA expression was higher in the 
fetal than postnatal liver (38). Interestingly, while it has been shown that glucose infusion into 
the pregnant ewe and resultant fetal hyperglycaemia result in a suppression of hepatic GLUT-1 
expression (38), we found no effect of the moderate increase in fetal glucose induced by 
increased maternal nutrition on hepatic GLUT-1 expression either before or after birth. 
There was a different impact of the transition from placental to enteral nutrition on the hepatic 
expression of PEPCK-M and PEPCK-C.  In contrast to PEPCK-M,  the  level  of  PEPCK-C  
expression was  significantly higher  in  the  liver  of  the postnatal lamb compared to the fetus. 
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Similarly, G6PHOS mRNA was expressed in the postnatal lamb liver in contrast to the 
negligible level of hepatic expression of G6PHOS mRNA in fetal life. It is well established that 
exposure to increased glucocorticoids induces hepatic PEPCK-C and gluconeogenesis in the 
fetal sheep (7-10). In the present study, hepatic 11βHSD1 mRNA expression was increased in 
postnatal compared to fetal life. Hepatic PGC-1 expression was also higher in the postnatal lamb 
compared to the fetus and there was the emergence of a relationship between hepatic PGC-1 and 
PEPCK-C mRNA expression in the lamb after birth. Thus in contrast to PEPCK-M, the 
transition from the fetal to the postnatal nutritional environment has a significantly greater 
impact on the regulation of PEPCK-C and G6PHOS than does exposure to maternal 
overnutrition in late gestation. 
Epigenetic changes in the PCK1 promoter after transition to postnatal life 
Intriguingly, in the current study we found that the increase in hepatic PEPCK-C expression 
which occurred after birth was associated with an increase in the level of methylation at 3 CpG 
dinucleotides (-88, -58 and -49) upstream of the transcription start site.  In contrast, it has been 
reported that the PCK1 gene is heavily methylated in the fetal rat liver and relatively under 
methylated in the adult liver (39). Whilst an increase in methylation at the 3 sites in the PCK1 
promoter would be expected to result in a decrease in the binding of transcription factors, 
including the cAMP response element-binding (CREB) protein, it is of note that the 3 CpG sites 
lie outside of the ‘glucocorticoid regulatory unit’ in PCK1. The increase in methylation at these 
3 CpG dinucleotides in the PCK1 promoter region may result in a suppression of ‘constitutive’ 
PCK1 expression to allow for the glucocorticoid induction of PCK1 which is important as the 
fetus makes the transition from continuous placental to intermittent enteral nutrition. 
There was no evidence that the epigenetic state of the PCK1 promoter was altered by exposure 
to either maternal overnutrition or prevailing high circulating glucose concentrations in fetal or 
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postnatal life. There is evidence from studies in the fetal baboon at 0.9 of gestation, that the level 
of methylation of a number of CpG sites (-82, -30, -5, +31, +99, +105) in the PCK1 gene was 
reduced after exposure to maternal undernutrition and that this decrease was associated with an 
increase in hepatic PEPCK-C mRNA expression (19). It appears therefore that maternal 
undernutrition and the transition from fetal to postnatal nutrition may each play different roles in 





Exposure to either a restriction or an oversupply of fetal nutrients can result in long term 
consequences for glucose tolerance and insulin sensitivity in later life (40,41).  We have 
investigated the impact of maternal overnutrition and separately the transition from placental to 
enteral nutrition on the factors which regulate hepatic gluconeogenesis, the expression of the 
cytosolic and mitochondrial isoforms of PEPCK and the epigenetic status of PCK1. We have 
shown that there is a differential impact of exposure to prenatal overnutrition on PEPCK-M and 
PEPCK-C expression in the postnatal liver. Further work is required to understand the 
mechanism by which maternal overnutrition programs a decrease in hepatic PCK2 expression 






Material and Methods 
Animals and Feeding Regimen 
All procedures were approved by the University of Adelaide Animal Ethics Committee. Merino 
ewes were mated and pregnancy confirmed by ultrasound scanning in early gestation. From 90 
days gestation ewes were acclimatized to a Control diet which consisted of 1 kg lucerne chaff 
(85% dry matter, metabolisable energy (ME) content = 8.3 MJ/kg) and 300 g concentrated 
pellets containing: straw, cereal, hay, clover, barley, oats, lupins, almond shells, oat husks and 
limestone (89% dry matter, ME content = 11.6 MJ/kg; Ridley Agriproducts Sheep Nutrition 
Ration, Murray Bridge, South Australia, Australia). The diet was calculated to provide 100% of 
the energy requirements for the maintenance of a pregnant ewe bearing a singleton fetus or twin 
fetuses as appropriate, as specified by the Ministry of Agriculture, Fisheries and Food, UK (20). 
Surgery was then performed on these ewes between 103 and 113days gestation (term = 147 +/- 3 
days) using aseptic techniques. General anaesthesia was induced by intravenous injection of 
sodium thiopentone (1.25 g i.v., Pentothal, Rhone Merieux, Pinkenba, Queensland, Australia) 
and maintained with 2.5 - 4% halothane (Fluothane, ICI, Melbourne, Victoria, Australia) in 
oxygen. Vascular catheters were implanted in a jugular vein and carotid artery of the ewe and 
fetus, and in the amniotic cavity, as previously described (21). During surgery intramuscular 
injections of antibiotics (2 ml Procaine penicillin 250 mg/ml, Dihydrostreptomycin 250 mg/ml, 
procaine hydrochloride 20 mg/ml, Lyppards, Adelaide, South Australia, Australia or 0.1 ml/kg 
Terramycin 100, 100 mg/ml oxytetracycline hydrochloride, Pfizer, New South Wales, Australia) 
were administered to each ewe and fetus. All catheters were filled with heparinised saline and 
the fetal catheters exteriorised through an incision in the ewe’s flank. Before and after surgery 
the ewes were housed in individual pens in animal holding rooms with a 12 h: 12 h light/dark 
cycle. If there was any evidence of a decline in fetal well-being after surgery, as indicated by a 
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decline in fetal oxygenation, ampicillin (5ml) was administered to that fetus via the amniotic 
catheter for a period of 4 days. 
At 115 days gestation, i.e. prior to the commencement of the rapid fetal growth phase in late 
gestation (22), ewes were randomly assigned to either a Control (n=14) or Well Fed (WF) (n= 
16) group. Between 115 and 124 days gestation, Control ewes were provided with 14.0 ± 0.4 g 
of lucerne chaff and 6.5 ± 0.4 g of pelleted concentrate per kg bodyweight and WF ewes were 
provided with 22.1 ± 0.8 g lucerne chaff and 10.4 ± 0.7 g pelleted concentrate per kg 
bodyweight each day. The feed allowance of all ewes was proportionately increased by 15% 
every 10 days (20). 
Fetal Blood Sampling 
Between 113 and 139 days gestation, maternal (5.0 ml) and fetal (3.0 ml) arterial blood samples 
were collected three times per week prior to feeding at 0900 h. Fetal arterial blood (0.5 ml) was 
collected three times per week for determination of fetal blood gases (PO2, PCO2), oxygen 
saturation, pH, hematocrit, and haemoglobin using an ABL 520 analyser (Radiometer, 
Copenhagen, Denmark). 
Collection of Fetal Tissues 
Between 139 and 141 days gestation, ewes from the Control group (n=6) and the WF group 
(n=8) were killed with sodium pentobarbitone (Virbac Pty Ltd., Peakhurst, New South Wales, 
Australia). Fetal sheep were delivered by hysterectomy, weighed and killed by decapitation. 
Livers were weighed and samples were collected, snap frozen in liquid N2 and stored at –80° C. 
All fetuses were singletons.  
 
Lamb Protocols and Tissue Collection 
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The remaining Control (n=8; 4 carrying twins, 4 singletons) and WF (n=8; 1 carrying twins, 7 
singletons) ewes lambed spontaneously at term. Both twins from each ewe were used in this 
study. After lambing, all ewes were provided with 1 kg lucerne chaff and 500 g pelleted 
concentrate once daily. If all feed was consumed before 1500 h, an additional 1 kg of chaff was 
provided. After birth, each ewe and her lamb(s) were housed in an individual pen in a facility 
maintained at 20-22 º C and a 12h light: 12h dark light cycle. The day of birth was designated as 
day 1. Venous blood samples were collected between 0800 h – 1300 h after a 2 h fast on days 1-
5 and every 3 days thereafter until day 30. All blood samples were centrifuged at 1500 g for 10 
min and plasma stored at -20°C.  
 
At 30 days of age, lambs were killed with an overdose of sodium pentobarbitone (Virbac Pty 
Ltd, Peakhurst, New South Wales, Australia). Livers were dissected out and weighed and 
samples were collected and snap frozen in liquid N2 and stored at –80° C. 
Plasma Glucose 
Plasma glucose concentrations were measured by enzymatic analysis using hexokinase and 
glucose-6-phosphate dehydrogenase to measure the formation of NADH photometrically at 340 
nm (COBAS MIRA automated analysis system, Roche Diagnostica, Basel, Switzerland) (21). 
The sensitivity of the assay was 0.5 mmol/l and the intra- and inter assay coefficients of 
variation were both < 5%. 
Plasma Insulin 
Plasma insulin concentrations were measured using a radioimmunoassay (Rat insulin kit, Linco 
Research, Inc., Missouri, USA), which was validated for use with sheep plasma (6). The 





Cortisol was extracted from fetal plasma using dichloromethane as previously described (23).  
Fetal cortisol concentrations were then measured using an Orion Diagnostica 
Radioimmunoassay kit (Orion Diagnostica, Turku, Finland) previously validated for fetal sheep 
plasma (24). The inter-assay coefficient of variation was 20% and the intra-assay coefficient of 
variation was < 10%. 
RNA Extraction 
RNA from the dorsal lobe of the liver (≈30mg) was extracted using Trizol reagent (Invitrogen 
Australia Pty Limited, Mount Waverley, Victoria,Australia) and chloroform. RNA was treated 
with 50% ethanol and run through a purification process using the RNeasy Mini Kit (QIAGEN 
Pty Ltd Australia, Doncaster, Victoria, Australia). The quality and concentration of the RNA 
was determined by measuring absorbance at 260 and 280 nm, and RNA integrity was confirmed 
by agarose gel electrophoresis. cDNA was then synthesised using the purified RNA (≈ 5µg), 
Superscript III Reverse Transcriptase (Invitrogen Australia Pty Limited, Mount Waverley, 
Victoria, Australia) and random hexamers. 
Quantitative Real Time Reverse Transcription-PCR (qRT-PCR) 
The relative expression of PGC-1, PPARα, PEPCK-M, PEPCK-C, G6PHOS, GLUT-1, GR and 
11βHSD1 mRNA transcripts were measured by qRT-PCR using the SYBR Green system in an 
ABI prism 7900 Sequence Detection System (PE Applied Biosystems, Foster City, California). 
(25). For each transcript qRT-PCR was performed using specific primers (Table 1). Each 
amplicon was designed to be approximately 200 bp in length, was sequenced to ensure the 
authenticity of the DNA product and qRT-PCR melt curve analysis was performed to 
demonstrate amplicon homogeneity. Controls containing no reverse transcriptase were also used. 
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For the qRT-PCR measurements, the primer concentrations were equivalent for all genes and the 
amplification efficiencies were 0.981-0.999. A constant amount of cDNA equating to 10ng of 
total RNA was used  for  each  qRT-PCR  measurement  and  three  technical  replicates  were  
performed  in duplicate for each gene.  
Each  qRT-PCR reaction (5µl  total  volume) contained: 2.5 µl 2x SYBR Green master mix 
(Applied Biosystems, Foster City, California, USA); 0.25 µl of each primer giving a final 
concentration of 450 µl, 1.0 µl of molecular grade H2O and 1.0 µl of a 1:10 dilution of the stock 
template. The cycling conditions consisted of 40 cycles of 95ºC for 15 seconds and 60ºC for 1 
minute. At the end of each run, a dissociation melt curve was obtained. 
The abundance of each mRNA transcript was measured and its expression relative to that of 
Ribosomal Protein Large Subunit P0 (RPLP0) was calculated using Q-gene qRT-PCR analysis 
software. There were no differences in the expression of the housekeeper gene between the 
Control and Well Fed groups in either the fetal or postnatal cohort. 
Combined Bisulphite Restriction Analysis 
DNA methylation within the PCK1 promoter region was analysed using combined bisulphite 
restriction assay (COBRA) (26). Briefly, approximately 2 µg of DNA from the ventral lobe of 
fetal and lamb liver was subjected to bisulphite conversion (EpiTect; QIAGEN Pty Ltd 
Australia, Doncaster, Victoria, Australia). PCR was then performed on 100 ng of bisulphite-
converted DNA using primers (Forward: 5’ TAAAGGTTTGTTATGGTTGGTTTAG 3’; 
Reverse: 3’ CTAACCTTTAAATTCCAAAAAAA 5’) and conditions that amplified methylated 
and unmethylated templates with no bias. The amplicon contained three CpG sites at -49, -58 
and -88 where +1 denotes the transcription start site. COBRA was performed using restriction 
endonucleases that cleave only those amplicons derived from methylated templates. The PCK1 
amplicon was digested with 20 U of TaqI (Thermo Fisher Scientific, Scoresby, Victoria, 
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Australia), MaeII and DpnII (New England Biolabs, Ipswich, Massachusetts, USA), which 
digests methylated templates at  -49,  -58  and  -88  respectively. The intensity of uncut and cut 
fragments was quantified using the ExperionTM Automated Electrophoresis System (Bio-Rad, 
Hercules, California, USA). The percentage of methylation was estimated by measuring the ratio 
of cut to total PCR product. 
Statistical Analyses 
Data are presented as the mean ± SEM. The fetal cohort comprised 6 Control fetuses (4 males 
and 2 females) and 8 fetuses from WF ewes (3 males and 5 females). The postnatal lamb cohort 
comprised 12 Control lambs (6 males and 6 females) and 9 lambs in the WF group (3 males and 
6 females). There were 14 singleton and no twins in the fetal group and 11 singletons and 10 twins in 
the postnatal lamb group. Using multifactorial ANOVA we found no significant effect (main effect or 
interaction with treatment group) of being a twin or of the sex of the lamb on the expression of any 
hepatic mRNA level and therefore data were combined for subsequent analysis. Two way 
Analysis of Variance (ANOVA) was then used to determine the main effects of maternal 
nutritional treatment (Control vs. WF) and developmental age (fetal vs. postnatal) and their 
interaction on birth weight, liver mass, and hepatic gene expression and the level of PCK1 
methylation. Simple linear regression analyses were used to determine relationships between 
postnatal measures of fat mass, plasma nutrient and hormone concentrations and gluconeogenic 
gene expression. Plasma glucose and insulin and cortisol concentrations across postnatal week 1 
– 4 were averaged for correlation analyses unless stated otherwise. Partial correlation analysis 
was used to control for the effects of maternal intake or mean plasma glucose levels where 
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Figure 1. (a) PEPCK-M mRNA expression in fetal and lamb livers in Control (open bars) and 
WF (closed bars) groups. * denotes a significant difference when compared to the Control group 
(P<0.05). (b) PEPCK-C mRNA expression in fetal and lamb livers in Control (open bars) and 
WF (closed bars) groups. ** denotes a significant difference between one month of age when 
compared to 139-141d gestation (P<0.001). † denotes that the level of difference between the 
WF and Control group was at the P= 0.06 level  
 
Figure 2. (a) PPARα mRNA expression in fetal and lamb livers in Control (open bars) and WF 
(closed bars) groups. ** denotes a significant difference between one month of age when 
compared to 139-141d gestation (P<0.01) (b) PGC-1 mRNA expression in fetal and lamb livers 
in Control (open bars) and WF (closed bars) groups ** denotes a significant difference between 
one month of age when compared to 139-141d gestation (P<0.01).  
 
Figure 3. GLUT1 mRNA expression in fetal and lamb livers in Control (open bars) and WF 
(closed bars) groups ** denotes a significant difference between one month of age when 
compared to 139-141d gestation (P<0.001). 
Figure 4. 11βHSD1 mRNA expression in fetal and lamb livers in Control (open 
bars) and WF (closed bars) groups. ** denotes a significant difference between one month of 
age when compared to 139-141d gestation (P<0.01). 
Figure 5. The level of methylation at each of the 3 CpG sites in the PCK1 promoter in the 
Control (open bars) and WF (closed bars) fetal sheep and lambs.** denotes a significant 
difference between one month of age when compared to 139-141d gestation (P<0.01).  
